Drug & Supplement Interactions

Psilocybin + Opicapone

Brand name of Opicapone

  • Ongentys

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated October 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Best Avoided

We found no known interaction between Psilocybin and Opicapone in our sources, but our pharmacy team rates Psilocybin itself best avoided. Psilocybin is a controlled substance with powerful mind-altering effects and is not a safe or legal dietary supplement.

This also applies to Ongentys, a brand name of opicapone.

Still Worth Knowing

  • Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Psilocybin with Opicapone. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Psilocybin and Opicapone Interaction Check

No Known Interaction, but Psilocybin Is Best Avoided

We did not find a documented interaction between Opicapone and Psilocybin in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Our pharmacy team rates Psilocybin best avoided, whatever else you take. Psilocybin is a controlled substance with powerful mind-altering effects and is not a safe or legal dietary supplement. See Psilocybin’s safety ratings →

How We Checked

Why No Interaction Is Listed for Opicapone

We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category Opicapone is in against every category Psilocybin has a known interaction with.

3Categories Opicapone Is In
  • Dopamine Agonists No Psilocybin Record
  • P-Glycoprotein Substrates Drugs that a pump called P-glycoprotein moves out of cells in the gut, liver and kidneys; when the pump slows or speeds up, their levels can rise or fall. No Psilocybin Record
  • Oral Drugs Any drug taken by mouth. No Psilocybin Record
2Drug Categories Psilocybin Interacts With

No overlap. Opicapone is in none of the 2 categories Psilocybin interacts with, so no record links the two.

Still wondering about combining Psilocybin and Opicapone? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

Side Effects Psilocybin and Opicapone Have in Common

6 side effects show up for both Psilocybin and Opicapone.

  • Each has separately been linked to the effects below. Taken together, they might add up: the same side effect from two sources might be more likely or stronger. No study of the two together says by how much.
  • If one turns up, it can be harder to tell which one is behind it, so tell your pharmacist you take both.
  • 2 of them are worth acting on rather than waiting out, marked below.
  • Hallucinations / Confusion Worth Acting On reported in 13.9% of FDA reports for Opicapone Additional detail

    Psilocybin

    Psilocybin has psychedelic or hallucinogenic effects, with side effects including visual, auditory, tactile, and other illusions, as well as changes in time and space perception, and "mystical experiences". The severity of some of these responses may be dose-dependent.

    Source: , the clinical database we license.

    6 references cited
    1. 106129. Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 2016;30(12):1181-1197. PubMed
    2. 106137. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 2015;29(3):289-99. PubMed
    3. 106138. Grob CS, Danforth AL, Chopra GS, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 2011;68(1):71-8. PubMed
    4. 106146. Brown RT, Nicholas CR, Cozzi NV, et al. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. Clin Pharmacokinet 2017;56(12):1543-1554. PubMed
    5. 106150. Griffiths RR, Johnson MW, Richards WA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial at
    6. 106154. Carbonaro TM, Bradstreet MP, Barrett FS, et al. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J Psychopharmacol 2016;30(12):1268-1278. PubMed

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section. Voluntary reports to the FDA mention it too.

    Read Opicapone’s label on DailyMed ›
  • Raised blood pressure Worth Acting On Additional detail

    Psilocybin

    Recorded for Psilocybin in the same Natural Medicines adverse-effect record shown under Hallucinations / Confusion above.

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›
  • Drowsiness / Dizziness Additional detail

    Psilocybin

    Orally, single doses of psilocybin have resulted in mild to moderate headache in numerous case studies and experimental studies. Headaches have been reported in up to 50% of individuals, starting a mean of 7 hours after intake and lasting for 1-2 days. Severity and duration seem to be dose-dependent.

    Source: , the clinical database we license.

    6 references cited
    1. 106129. Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 2016;30(12):1181-1197. PubMed
    2. 106131. Carhart-Harris RL, Bolstridge M, Day CMJ, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl) 2018;235(2):399-408. PubMed
    3. 106132. Ross S, Bossis A, Guss J, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 2016;30(12):1165-1180. PubMed
    4. 106134. Carhart-Harris RL, Bolstridge M, Rucker J, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 2016;3(7):619-27. PubMed
    5. 106135. Davis AK, Barrett FS, May DG, et al. Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry 2021;78(5):481-489. PubMed
    6. 106137. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 2015;29(3):289-99. PubMed

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›
  • Trouble sleeping Additional detail

    Psilocybin

    Orally, single doses of psilocybin have resulted in nausea, and rarely, vomiting and diarrhea. Analysis from a large clinical trial that evaluated single doses of psilocybin 1 mg, 10 mg, and 25 mg suggests that for every 5 patients treated with psilocybin 25 mg over psilocybin 1 mg, one additional case of nausea will occur.

    Source: , the clinical database we license.

    6 references cited
    1. 106129. Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 2016;30(12):1181-1197. PubMed
    2. 106131. Carhart-Harris RL, Bolstridge M, Day CMJ, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl) 2018;235(2):399-408. PubMed
    3. 106132. Ross S, Bossis A, Guss J, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 2016;30(12):1165-1180. PubMed
    4. 106134. Carhart-Harris RL, Bolstridge M, Rucker J, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 2016;3(7):619-27. PubMed
    5. 106137. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 2015;29(3):289-99. PubMed
    6. 106161. Carbonaro TM, Johnson MW, Griffiths RR. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. Psychopharmacology (Berl) 2020;237(8):2293-2304. PubMed

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›

Reported for Psilocybin but not commonly for Opicapone: a heart attack, a slow heartbeat, dependence or withdrawal symptoms and mood changes or irritability.

Note: Effects for Opicapone come from the Adverse Reactions section of its FDA label; effects for Psilocybin come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 2,261 voluntary FDA FAERS reports for Opicapone that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. The two sources word some effects differently, so we match them by meaning.

If You Already Take Both
  • Tell your pharmacist or doctor that you take Psilocybin, so they can check it against everything else you take.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Psilocybin Does Interact With Other Medications

Psilocybin has 293 moderate known drug interactions in our database — Opicapone isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Psilocybin

Covers the 2,830 medications we’ve checked against Psilocybin. Pick one to open its full report.

Alternatives for the Same Use

Other Supplements Studied for Depression, and How They Mix With Opicapone

Choosing a supplement while you take Opicapone? Here are other options studied for depression, and whether each has a documented interaction with Opicapone.

1 of them has a documented interaction with Opicapone: St. John's Wort (major).

10 other supplements have at least some evidence of a benefit for depression; the 8 below come first. Psilocybin itself is graded for it.

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Everything Else You Take

See Every Supplement That Interacts With Opicapone

Take other supplements too? 59 supplements have a documented interaction with Opicapone, each explained on its page.

By severity: 2 major, 40 moderate and 17 minor.

The Most Serious There Right Now:

Open the Opicapone interaction pageEvery supplement checked against Opicapone, ranked by severity

Get to Know Each One

About Psilocybin and Opicapone

Supplement

About Psilocybin

Psilocybin is a powerful psychedelic compound found in certain mushrooms and is being studied for hard-to-treat depression, anxiety, and addiction, but it is still investigational and not an approved supplement. It is illegal in most places, can cause intense and unpredictable mental effects, and should never be used outside of a supervised clinical setting.

Full Psilocybin guide: uses, dosage, safety and every interaction
Safety at a Glance

How Psilocybin Is Rated

  • Psilocybin Overall

    Avoid

    Psilocybin is a controlled substance with powerful mind-altering effects and is not a safe or legal dietary supplement.

  • Pregnancy

    Avoid

    There is no safety data; avoid during pregnancy.

  • Breastfeeding

    Avoid

    There is no safety data; avoid while breastfeeding.

Medication

About Opicapone

Brand name: Ongentys

Opicapone (sold as Ongentys capsules) is used along with levodopa/carbidopa in people with Parkinson’s disease who have “off” episodes. These are times when Parkinson’s symptoms return between doses of levodopa.

Opicapone: uses, dosage and side effects Opicapone: interactions with other drugs Taking more than these two? Check Psilocybin and Opicapone with everything else you take Opicapone NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Psilocybin

Browse every other medication we’ve checked against Psilocybin — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
293Moderate
0Minor
2,536No known interaction
Moderate

Moderate: 293 interactions

Showing 60 of 293 moderate interactions — see all 293 on the Psilocybin page.

No Interaction 2,536 drugs checked — show the list
How Much People Look This Up

Where Psilocybin and Opicapone Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Psilocybin
Top 25%

#199 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Opicapone
Top half

#1,014 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Psilocybin and Opicapone Together: Common Questions

Can you take Psilocybin with Opicapone?
We do not list a known interaction between Psilocybin and Opicapone, but that is not a reason to take Psilocybin: our pharmacy team rates it best avoided, whatever else you take. Psilocybin is a controlled substance with powerful mind-altering effects and is not a safe or legal dietary supplement. Talk with your pharmacist or doctor before taking it, and do not stop or change Opicapone on your own.
Can you take Psilocybin with Ongentys?
Ongentys is a brand name of opicapone, so the answer is the same as for opicapone. We do not list a known interaction between Psilocybin and Opicapone, but that is not a reason to take Psilocybin: our pharmacy team rates it best avoided, whatever else you take. Everything on this page applies to Ongentys too.
Do Psilocybin and Opicapone have any of the same side effects?
Yes — our sources link each of them separately to 6 of the same effects. That is not a documented interaction, but taken together the same side effect from two sources might be more likely or stronger; no study of the two together says by how much. And if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the Psilocybin and Opicapone combination checked?
Interactions in our licensed database are recorded against drug classes. Opicapone is filed under 3 classifications, and Psilocybin has documented interactions with 2 drug classes — none of Opicapone's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Do other supplements studied for depression interact with Opicapone?
1 of the 10 other supplements the Natural Medicines database grades as having some evidence of a benefit for depression has a documented interaction with Opicapone: St. John's Wort (major). A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Psilocybin interact with any other medications?
Yes. Psilocybin has 293 documented drug interactions in our database — Opicapone is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Opicapone interact with any supplements?
Yes. Opicapone has documented interactions with 59 supplements in our database — Psilocybin is not one of them. The Opicapone interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 11 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 11 references
  1. 106129. Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 2016;30(12):1181-1197. PubMed
  2. 106131. Carhart-Harris RL, Bolstridge M, Day CMJ, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl) 2018;235(2):399-408. PubMed
  3. 106132. Ross S, Bossis A, Guss J, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 2016;30(12):1165-1180. PubMed
  4. 106134. Carhart-Harris RL, Bolstridge M, Rucker J, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 2016;3(7):619-27. PubMed
  5. 106135. Davis AK, Barrett FS, May DG, et al. Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry 2021;78(5):481-489. PubMed
  6. 106137. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 2015;29(3):289-99. PubMed
  7. 106138. Grob CS, Danforth AL, Chopra GS, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 2011;68(1):71-8. PubMed
  8. 106146. Brown RT, Nicholas CR, Cozzi NV, et al. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. Clin Pharmacokinet 2017;56(12):1543-1554. PubMed
  9. 106150. Griffiths RR, Johnson MW, Richards WA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial at
  10. 106154. Carbonaro TM, Bradstreet MP, Barrett FS, et al. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J Psychopharmacol 2016;30(12):1268-1278. PubMed
  11. 106161. Carbonaro TM, Johnson MW, Griffiths RR. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. Psychopharmacology (Berl) 2020;237(8):2293-2304. PubMed

All 65 references behind our Psilocybin records are listed in the Psilocybin guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 22, 2026. The Psilocybin and Opicapone records this page draws on were last updated October 20, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Psilocybin and Opicapone?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.